These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 3424290)

  • 1. Human platelet aggregation by PAF and thromboxane production.
    Violi F; Praticò D; Ghiselli A; Alessandri C; Cordova C
    Thromb Res; 1987 Oct; 48(2):265-6. PubMed ID: 3424290
    [No Abstract]   [Full Text] [Related]  

  • 2. Benzodiazepine analogues inhibit arachidonate-induced aggregation and thromboxane synthesis in human platelets.
    Fonlupt P; Croset M; Lagarde M
    Br J Pharmacol; 1990 Dec; 101(4):920-4. PubMed ID: 1964822
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro effects of gallopamil on platelet aggregation and thromboxane generation.
    Davì G; Novo S; Mattina A; Catalano I; Strano A
    Arzneimittelforschung; 1988 May; 38(5):698-9. PubMed ID: 3415711
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Platelet-activating factor (PAF-acether) secretion from platelets: effect of aggregating agents.
    Chignard M; Le Couedic JP; Vargaftig BB; Benveniste J
    Br J Haematol; 1980 Nov; 46(3):455-64. PubMed ID: 6778498
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Absence of platelet activating factor (PAF) mediated platelet aggregation: a new platelet defect.
    Pelczar-Wissner CJ; McDonald EG; Sussman II
    Am J Hematol; 1984 May; 16(4):419-22. PubMed ID: 6720685
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lack of thromboxane A2 synthesis in platelet aggregation induced by factor VIII/von Willebrand factor.
    Kao KJ; Pizzo SV
    Thromb Res; 1981 Nov; 24(3):245-51. PubMed ID: 6801805
    [No Abstract]   [Full Text] [Related]  

  • 7. [Effects of isosorbide dinitrate on platelet aggregation and production of thromboxane B2].
    De Caterina R; Crea F; Giannessi D; Bernini W; Gazzetti P; Chierchia S; Distante A; L'Abbate A
    Cardiologia; 1982; 27(3):315-7. PubMed ID: 6892461
    [No Abstract]   [Full Text] [Related]  

  • 8. Effects of platelet aggregation and adenosine 3':5'-monophosphate on the synthesis of thromboxane B2 in human platelets.
    Lindgren JA; Claesson HE; Kindahl H; Hammarström S
    Adv Prostaglandin Thromboxane Res; 1980; 6():275-81. PubMed ID: 6247886
    [No Abstract]   [Full Text] [Related]  

  • 9. Thromboxane B2 production and lipid peroxidation in human blood platelets.
    Best LC; Jones PB; McGuire MB; Russell RG
    Adv Prostaglandin Thromboxane Res; 1980; 6():297-9. PubMed ID: 7386271
    [No Abstract]   [Full Text] [Related]  

  • 10. Unsaturated platelet-activating factor: influence on aggregation, serotonin release and thromboxane synthesis of human thrombocytes.
    Korth R; Riess H; Brehm G; Hiller E
    Thromb Res; 1986 Mar; 41(5):699-706. PubMed ID: 3961742
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of adenosine 3':5'-monophosphate and platelet aggregation on thromboxane biosynthesis in human platelets.
    Lindgren JA; Claesson HE; Kindahl H; Hammarström S
    FEBS Lett; 1979 Feb; 98(2):247-50. PubMed ID: 217731
    [No Abstract]   [Full Text] [Related]  

  • 12. Platelet activation by platelet aggregation factor from Eisenia foelide.
    Qian R; Zhou YC; Zhuang QQ
    Zhongguo Yao Li Xue Bao; 1994 Sep; 15(5):432-5. PubMed ID: 7717070
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of platelet thromboxane formation and phosphoinositides breakdown by diisoeugenol.
    Lin CH; Kuo YH; Lin YL; Teng CM
    J Pharm Pharmacol; 1994 Jan; 46(1):54-7. PubMed ID: 8201527
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human platelet activation by an alkylacetyl analogue of phosphatidylcholine.
    Rao GH; Schmid HH; Reddy KR; White JG
    Biochim Biophys Acta; 1982 Apr; 715(2):205-14. PubMed ID: 6280777
    [No Abstract]   [Full Text] [Related]  

  • 15. ADP-, PAF- and adrenaline-induced platelet aggregation and thromboxane formation are not affected by a thromboxane receptor antagonist at physiological external Ca++ concentrations.
    Bretschneider E; Glusa E; Schrör K
    Thromb Res; 1994 Aug; 75(3):233-42. PubMed ID: 7992234
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interaction of a new low molecular weight heparin (OP/LMWH) with human platelets.
    Mastacchi R; Barbanti M; Bianchini P; Osima B
    Agents Actions; 1986 Mar; 17(5-6):512-4. PubMed ID: 3518359
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ex vivo effects of ticlopidine on human platelets: inhibition of fibrinogen binding by a mechanism independent of thromboxane formation.
    Iovine C; d'Avenia V; Turco S; Mattioli PL; di Minno G
    Agents Actions Suppl; 1984; 15():105-7. PubMed ID: 6592941
    [No Abstract]   [Full Text] [Related]  

  • 18. Endotoxin interaction with canine platelets fails to stimulate thromboxane production.
    Harris RH; Schmeling JW; Fletcher JR; Ramwell PW
    Proc Soc Exp Biol Med; 1982 Mar; 169(3):397-400. PubMed ID: 7038697
    [No Abstract]   [Full Text] [Related]  

  • 19. Inhibition of platelet aggregation and thromboxane B2 production during aspirin treatment: dependence on the dose of the aggregating agent.
    De Caterina R; Giannessi D; Gazzetti P; Bernini W
    Thromb Res; 1985 Jan; 37(2):337-42. PubMed ID: 3975876
    [No Abstract]   [Full Text] [Related]  

  • 20. Calcium-dependent stimulation of thromboxane and prostaglandin biosynthesis by ionophores.
    Oelz O; Knapp HR; Roberts LJ; Oelz R; Sweetman BJ; Oates JA; Reed PW
    Adv Prostaglandin Thromboxane Res; 1978; 3():147-58. PubMed ID: 350020
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.